CLINICAL_TRIALS
trial_result
· 2011-04-12
Clinical Trial Update: Consistency Lots Vaccine Study (V260-009) [Phase 3]
Summary
Phase 3 consistency lots study of a rotavirus vaccine (V260-009) sponsored by Merck Sharp & Dohme LLC has completed. Results were posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Rotavirus Infections | Phase 3 | Status: COMPLETED | Results posted: 2011-04-12